SEQUANA MEDICAL NV (SEQUA.BR) Stock Analyst Earnings Estimates
EBR:SEQUA - Euronext Brussels - BE0974340722 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 370.5K -61.54% | 922.7K 149.04% | 712.2K -22.81% | 105.06K -85.25% | 11.296M 10,651.95% | 14.832M 31.30% | |
| EBITDA YoY % growth | -22.205M -29.81% | -27.783M -25.12% | -28.201M -1.50% | -18.883M 33.04% | -9.013M 52.27% | -13.545M -50.29% | |
| EBIT YoY % growth | -22.614M -29.87% | -28.095M -24.24% | -28.862M -2.73% | -17.17M 40.51% | -13.031M 24.11% | -15.553M -19.35% | |
| Operating Margin | -6,103.54% | -3,044.81% | -4,052.54% | -16,343.46% | -115.36% | -104.86% | |
| EPS YoY % growth | N/A 6.02% | N/A 3.73% | N/A 7.20% | -0.50 56.12% | -0.31 38.10% | -0.35 -12.09% |
All data in EUR
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 50.00% | -0.12 58.62% | -0.12 33.33% | -0.12 20.00% | -0.10 33.33% | -0.10 16.67% |
| Revenue Q2Q % growth | 103K -56.52% | 103K -68.60% | 103K | 103K -2.37% | 103K | 206K 100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.901M 41.06% | -4.901M 63.55% | N/A | N/A | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 53.13% | -0.15 | % | |
| Q1 2024 Q2Q % growth | 48.57% | -0.19 | % | |
| Q4 2023 Q2Q % growth | 9.38% | -0.30 | % | |
| Q3 2023 Q2Q % growth | 6.25% | -0.31 | % | |
| Q2 2023 Q2Q % growth | 52.94% | -0.33 | % | |
| Q1 2023 Q2Q % growth | -16.67% | -0.36 | % | |
| Q4 2022 Q2Q % growth | -6.67% | -0.33 | % | |
| Q3 2022 Q2Q % growth | -0.33 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 105.5K -72.54% | 103K | 2.5K | 2.43% |
| Q1 2024 Q2Q % growth | -60.00% | 103K | % | |
| Q4 2023 Q2Q % growth | 328K -28.42% | 257.5K | 70.5K | 27.38% |
| Q3 2023 Q2Q % growth | 15.00% | 236.9K | % | |
| Q2 2023 Q2Q % growth | 384.2K -17.29% | 267.8K | 116.4K | 43.47% |
| Q1 2023 Q2Q % growth | 1,566.67% | 257.5K | % | |
| Q4 2022 Q2Q % growth | 458.2K 31.67% | 206K | 252.2K | 122.43% |
| Q3 2022 Q2Q % growth | 1,233.33% | 206K | % | |
| Q2 2022 Q2Q % growth | 464.5K 1,964.44% | 15.45K | 449.05K | 2,906.47% |
| Q4 2021 Q2Q % growth | 348K -5.59% | 15.45K | 332.55K | 2,152.43% |
| Q2 2021 Q2Q % growth | 22.5K -96.22% | % | ||
| Q4 2020 Q2Q % growth | 368.6K -33.90% | % | ||
| Q2 2020 Q2Q % growth | 594.7K 44.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 35.24% |
| Revenue | 0% | 0% | -33.33% | -61.75% |